Drawing for GX EXCELLA

USPTO serial 88238636

GX EXCELLA

Reviewed by CopyMark Law Group

Reg. 6325047Status 700Renewal
Filing date
Status date
Registration date
Apr 20, 2021
Examiner
KHAN, AHSEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GX EXCELLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander P. Montgomery

Alexander P. Montgomery Hinckley, Allen & Snyder, LLP28 State Street, 30th FloorBoston, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
009Dosing systems comprised of devices for dispensing pre-determined dosages of liquids or solids used in laboratories; laboratory supplies, namely, test tubes pipettes, flasks for laboratory use, volumetric flasks, vials for laboratory use, insulated bottles for laboratory use, plates for laboratory use, laboratory beakers, laboratory trays, laboratory filters, laboratory storage tubes, dosage dispensers, cuvettes; measuring containers, namely, containers specially design to carry measuring equipment used in laboratories; laboratory glass, namely, glass tubes for scientific purposes flasks for laboratory use, volumetric flasks, vials for laboratory use, insulated bottles for laboratory use, plates for laboratory use, laboratory beakers, cuvettes; containers, packaging and application systems and administering devices of glass in the nature of test tubs, for use in laboratoriesACTIVE—
010Medical instruments and apparatus, in particular, syringes featuring safety and administering accessories; medical instruments and apparatus, in particular, infusion systems, consisting primarily of infusion sets, medical infusion and injection devices for administering drugs, infusion apparatuses for infusion of blood, blood substitutes, plasma and infusion solutions, and infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical instruments and apparatus, in particular, transfusion systems, consisting primarily of transfusion sets, transfusion apparatuses for transfusion of blood, blood substitutes, plasma and other transfusion media, and medical tubing for transfusions; and medical instruments and apparatus, in particular, inhalation systems, consisting primarily of inhalers for medical purposes sold empty, particularly powder inhalers and capsule inhalers, and nebulizers for medical use, medical apparatus for facilitating the inhalation of pharmaceutical preparations, medical apparatus for administering medication in the form of an aerosol; dosing systems and administering devices for medical purposes in the nature of medical tubing for administering drugsACTIVE—
020Containers and packaging containers of plastic for commercial use in particular for the perfume, cosmetics and pharmaceutical industries, for use in medical technology, laboratories, and for the food and drink industries; cans of plastic for the aforesaid goods used as commercial containers; closures for containers, not of metalACTIVE—
021Containers, packaging and application systems and administering devices of glass, and parts, pre-products and accessories therefor, in particular for the perfume, cosmetics and pharmaceutical industries, for use in medical technology, the food and drink industries in the nature of bottles sold empty; bottles sold empty, drinking glasses, flasks, glass vials sold empty, glass cartridges for medication sold empty, flacons in the nature of bottles sold empty, glass tubes not for scientific purposes, dishes; pre-products for containers, packaging and application systems and administering devices of glass for use in laboratories in the nature of industrial packaging containers of glassACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 12, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 12, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 20, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 14, 2021ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 19, 2020ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 3, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 3, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 28, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 2, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 2, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 2, 2020CNSISUSPENSION INQUIRY WRITTEN—
Mar 12, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 17, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 27, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 27, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Aug 27, 2019CNSLSUSPENSION LETTER WRITTEN—
Aug 27, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Aug 27, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 27, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 27, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 24, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 24, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2019ALIEASSIGNED TO LIE—
Aug 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 18, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 18, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 18, 2019DOCKASSIGNED TO EXAMINER—
Jan 14, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 25, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance